Status:

UNKNOWN

GWAS Research of Lung Cancer in Tianjin

Lead Sponsor:

Tianjin Medical University Cancer Institute and Hospital

Conditions:

Non-small Cell Lung Cancer

Primary Carcinoma

Eligibility:

FEMALE

35-80 years

Brief Summary

To study the association of Genetic Polymorphisms with Lung Cancer Risk in Tianjin Population.

Detailed Description

Eligibility criteria: * nonsmoker * female * age between 35 and 80 * no other types of tumors history * frequency-matched cases and controls on gender and age Outcome measures: * OR(odds ratio) * R...

Eligibility Criteria

Inclusion

  • Non-small cell lung cancer
  • Age from 35 to 80 years old
  • Female
  • Non-smokers
  • Frequency-matched on age and gender

Exclusion

  • Previous medical history of cancer
  • Previous radiotherapy
  • Previous chemotherapy

Key Trial Info

Start Date :

June 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2016

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT01255059

Start Date

June 1 2010

End Date

December 1 2016

Last Update

December 22 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tianjin Medical University Cancer Institute and Hospital

Tianjin, Tianjin Municipality, China, 300060

GWAS Research of Lung Cancer in Tianjin | DecenTrialz